What are the contraindications for citalopram (Celexa) and the unrecognized medication Coercitan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications for Citalopram (Celexa)

Citalopram is absolutely contraindicated with MAOIs, pimozide, and in patients with known hypersensitivity to the drug. 1

Absolute Contraindications

Based on FDA labeling and clinical guidelines, the following are strict contraindications for citalopram:

1. Monoamine Oxidase Inhibitors (MAOIs)

  • Concomitant use with MAOIs is contraindicated due to severe risk of serotonin syndrome, which can be fatal 1
  • This includes phenelzine, isocarboxazid, moclobemide, isoniazid, and linezolid 2
  • Critical timing: Do not use citalopram within 14 days of discontinuing an MAOI 1
  • Serotonin syndrome manifests with mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity), and autonomic hyperactivity (hypertension, tachycardia, arrhythmias) 2
  • Advanced symptoms include fever, seizures, arrhythmias, and unconsciousness leading to death 2

2. Pimozide

  • Absolute contraindication due to pharmacodynamic interaction 1
  • Co-administration causes QTc prolongation of approximately 10 msec, increasing risk of torsades de pointes 1

3. Known Hypersensitivity

  • Contraindicated in patients with hypersensitivity to citalopram or any inactive ingredients 1

Critical Warnings and High-Risk Situations

Long QT Syndrome and QTc Prolongation

  • Avoid citalopram in patients with congenital long QT syndrome 2
  • Citalopram causes dose-dependent QTc prolongation associated with torsades de pointes, ventricular tachycardia, and sudden death 2
  • Maximum dose restrictions: Do not exceed 40 mg/day in adults; reduce to 20 mg/day maximum in patients >60 years old 3
  • Exercise extreme caution when combining with other QTc-prolonging drugs 2

Uncontrolled Hypertension

  • While not an absolute contraindication for citalopram alone, naltrexone/bupropion ER (which contains bupropion) is contraindicated in uncontrolled hypertension 4, 5
  • Abrupt citalopram discontinuation can paradoxically cause new-onset hypertension 6

Drug Interactions Requiring Extreme Caution

Serotonergic drugs - High risk of serotonin syndrome when combined with:

  • Other SSRIs, SNRIs, TCAs 2
  • Triptans (sumatriptan, etc.) - monitor closely for weakness, hyperreflexia, incoordination 1
  • Tramadol, meperidine, methadone, fentanyl 2
  • Dextromethorphan, St. John's Wort, L-tryptophan 2
  • Lithium - enhances serotonergic effects; monitor lithium levels 1

Drugs affecting hemostasis:

  • NSAIDs, aspirin, warfarin increase bleeding risk 1
  • Monitor INR closely when initiating or discontinuing citalopram in patients on warfarin 1

Special Populations

Pregnancy and Breastfeeding

  • Patients should notify physician if pregnant, planning pregnancy, or breastfeeding 1
  • All weight management medications containing antidepressants are contraindicated in pregnancy 5

Elderly Patients (>60 years)

  • Maximum dose reduced to 20 mg/day due to increased QTc prolongation risk 3
  • Higher risk of cardiac arrest (OR 1.21 for SSRIs) 3

Seizure Disorders

  • Use cautiously in patients with seizure history 2
  • Seizures reported in overdose settings 7

Regarding "Coercitan"

Coercitan is not a recognized medication name in standard pharmaceutical databases or FDA-approved drug lists. This may be:

  • A misspelling or regional name for another medication
  • A compounded or non-FDA approved product
  • A medication available outside the United States

Without identification of what "Coercitan" actually contains, no specific contraindications can be provided. If this is a combination product or alternative name, clarification of its active ingredients is essential before assessing contraindications with citalopram.

Clinical Pitfalls to Avoid

  1. Do not abruptly discontinue citalopram - can cause withdrawal syndrome (dizziness, nausea, anxiety, irritability) and new-onset hypertension 6
  2. Screen baseline ECG in patients with cardiac risk factors or on QTc-prolonging drugs 3
  3. Monitor closely in first 1-2 weeks for suicidal ideation, especially in patients <24 years 1
  4. Avoid alcohol during treatment 1
  5. Watch for sexual dysfunction in adolescents and adults - common but underreported 2

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

american association of clinical endocrinology consensus statement: algorithm for the evaluation and treatment of adults with obesity/adiposity-based chronic disease - 2025 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025

Research

Citalopram Overdose: a Fatal Case.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.